BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11126208)

  • 21. A controlled trial using ephedrine in the treatment of obesity.
    Pasquali R; Baraldi G; Cesari MP; Melchionda N; Zamboni M; Stefanini C; Raitano A
    Int J Obes; 1985; 9(2):93-8. PubMed ID: 3897082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
    Finer N; James WP; Kopelman PG; Lean ME; Williams G
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):306-13. PubMed ID: 10757623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
    Westerterp-Plantenga MS; Lejeune MP; Kovacs EM
    Obes Res; 2005 Jul; 13(7):1195-204. PubMed ID: 16076989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition.
    Greenway FL; De Jonge L; Blanchard D; Frisard M; Smith SR
    Obes Res; 2004 Jul; 12(7):1152-7. PubMed ID: 15292480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of sibutramine on energy expenditure and body composition in obese adolescents.
    Van Mil EG; Westerterp KR; Kester AD; Delemarre-van de Waal HA; Gerver WJ; Saris WH
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1409-14. PubMed ID: 17264187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of thermogenic drugs.
    Astrup A; Toubro S; Christensen NJ; Quaade F
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):246S-248S. PubMed ID: 1345887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
    Belza A; Frandsen E; Kondrup J
    Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
    JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
    Boozer CN; Nasser JA; Heymsfield SB; Wang V; Chen G; Solomon JL
    Int J Obes Relat Metab Disord; 2001 Mar; 25(3):316-24. PubMed ID: 11319627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns.
    Karhunen L; Franssila-Kallunki A; Rissanen P; Valve R; Kolehmainen M; Rissanen A; Uusitupa M
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1567-72. PubMed ID: 11126207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture.
    Dulloo AG; Miller DS
    J Nutr; 1987 Feb; 117(2):383-9. PubMed ID: 3559753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
    Shekelle PG; Hardy ML; Morton SC; Maglione M; Mojica WA; Suttorp MJ; Rhodes SL; Jungvig L; Gagné J
    JAMA; 2003 Mar; 289(12):1537-45. PubMed ID: 12672771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2004 Apr; 75(4):259-73. PubMed ID: 15060505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolic effects of preferential reduction of visceral adipose tissue in abdominally obese men.
    Marks SJ; Chin S; Strauss BJ
    Int J Obes Relat Metab Disord; 1998 Sep; 22(9):893-8. PubMed ID: 9756248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
    Heymsfield SB; Greenberg AS; Fujioka K; Dixon RM; Kushner R; Hunt T; Lubina JA; Patane J; Self B; Hunt P; McCamish M
    JAMA; 1999 Oct; 282(16):1568-75. PubMed ID: 10546697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.
    Ohara T; Muroyama K; Yamamoto Y; Murosaki S
    Nutr J; 2016 Jan; 15():6. PubMed ID: 26786000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.